Skip to main content

Table 1 Demographic data and classic CSF biomarker levels

From: Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Group Age (years) n (gender) CSF Aβ42 (pg/mL) CSF T-tau (pg/mL) CSF P-tau (pg/mL)
NADC 70 ± 2 [55–88] n = 26 (8F/18M) 773 ± 29 [1010–561] 238 ± 13 [138–365] 36 ± 2 [21–51]
AD 71 ± 1 [55–86] n = 27 (20F/7M) 414 ± 15* [544–251] 689 ± 48* [1420–443] 88 ± 5* [164–61]
  1. Patients were designated as NADC or AD according to CSF biomarker levels using cutoffs as described in the “Methods” section (and ref. [27]). The data represent the means ± SEM. The ranges of values for each variable are also indicated. F female; M male. *Significantly different (p < 0.001) from the NADC group